<DOC>
	<DOCNO>NCT02030535</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety orally inhaled tiotropium olodaterol fix dose combination free combination respect lung function ECG parameter</brief_summary>
	<brief_title>Study Evaluate Effect Lung Function ECG When Combination Tiotropium Plus Olodaterol Administered Patients With COPD Either From Single Inhaler Each Compound Administered After Each Other From Two Different Inhalers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : patient must sign informed consent consistent ICHGCP guideline prior participation trial , include medication washout restriction . Patients must diagnosis COPD must meet follow spirometric criterion : Patients must relatively stable airway obstruction postbronchodilator ( 10 45 minute 400mcg salbutamol ) FEV1 &gt; 30 % &lt; 80 % predict normal ( ECSC , GOLD II III ) postbronchodilator FEV1/FVC &lt; 70 % Visit 1 Male female patient , 40 year age old . Patients must current exsmokers smoke history 10 pack year . Patients never smoke cigarette must exclude . Patients must able perform technically acceptable pulmonary function test accord ATS/ERS guideline maintain record paper diary Patients must able inhale medication competent manner RESPIMAT inhaler meter dose inhaler ( MDI ) . Exclusion criterion : Significant disease COPD Clinically relevant abnormal lab value . History asthma . Diagnosis thyrotoxicosis Diagnosis paroxysmal tachycardia History myocardial infarction within 1 year screen visit Unstable lifethreatening cardiac arrhythmia Hospitalization heart failure within past year Known active tuberculosis Malignancy patient undergone resection , radiation therapy chemotherapy within last five year History lifethreatening pulmonary obstruction patient chronic respiratory failure History cystic fibrosis Clinically evident bronchiectasis History significant alcohol drug abuse Thoracotomy pulmonary resection Patients treat oral patch ßadrenergics Patients treat oral corticosteroid medication unstable dos dose excess 10mg prednisolone per day equivalent Regular use daytime oxygen therapy one hour per day Pulmonary rehabilitation program six week prior screen visit patient currently pulmonary rehabilitation program Investigational drug within one month six half life ( whichever great ) prior screen visit Known hypersensitivity ßadrenergic and/or anticholinergic drug , BAC , EDTA Pregnant nursing woman Women childbearing potential use highly effective method birth control Patient previously randomize study currently participate another study Patients unable comply pulmonary medication restriction prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>